Little Rock, AR, United States of America

Mariano Martinez

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Bioventures, LLC, Cornell University, New York Botanical Garden. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mariano Martinez: Innovator in Cancer Research

Introduction

Mariano Martinez is an accomplished inventor based in Little Rock, AR (US). He holds a patent that contributes to the field of cancer research, specifically targeting leukemic cancer cells. His innovative work showcases the potential of scientific advancements in improving health outcomes.

Latest Patents

Mariano Martinez is credited with a patent titled "Hetero-substituted cyclic lactone analogues and uses thereof." This patent provides a detailed disclosure of SL and SL derivatives that include a polar substituent adjacent to the lactone ring. The methods outlined in this patent aim to inhibit the growth of leukemic cancer cells, highlighting the significance of his research in the medical field.

Career Highlights

Throughout his career, Mariano has worked with notable organizations such as Bioventures, LLC and the New York Botanical Garden. His experience in these companies has allowed him to develop and refine his innovative ideas, contributing to advancements in cancer treatment.

Collaborations

Mariano has collaborated with professionals like Darin E Jones and Monica L Guzman. These partnerships have likely enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Mariano Martinez is a significant figure in the realm of cancer research, with a patent that demonstrates his commitment to innovation and improving health outcomes. His contributions are vital in the ongoing fight against cancer.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…